CAV2 and head and neck squamous cell carcinoma: The results of ubiquitination assays showed reduced ubiquitination of S100A14 in CAV2-silenced HNSCC cells, indicating that CAV2 enhances S100A14 ubiquitination and subsequent proteasomal degradation.